All In MedTech

Device Trial Radar · NCT02685956

Clinical Evaluation of the Sentosa SA HSV1/2 Qualitative PCR Test

Last checked: Nov 20, 2026Latest source record: Jun 5, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

2,295

Actual

Start

Apr 2016

Primary completion

Apr 7, 2017

Study completion Apr 7, 2017

Sponsor

Lead sponsor
Vela DiagnosticsNot on our public-company list
Sponsor type
Industry
First posted
Feb 19, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the performance of the Sentosa SA HSV1/2 Qualitative PCR Test. Precision of results and concordance of results with a reference assay will be evaluated.

Conditions

  • Herpes Simplex

Interventions

  • Vela Sentosa SA HSV1/2 Qualitative PCR TestDevice

    medical device test using Vela Sentosa SA HSV1/2 Qualitative PCR Test

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Positive and Negative for HSV-1 by SA201 HSV-1/2 PCR TestTime frame: within 60 days of last sample enrollment

1 more outcomes with a free account

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • Tampa General Hospital

    Tampa, Florida

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.